#AstraZeneca
articles
Markets
IC Podcast: $400bn Pharma Rumour, AI Jobs Fears, and Smith & Nephew’s Stalled Turnaround
Investors’ Chronicle weighs a rumoured AstraZeneca–Bristol Myers megamerger, probes whether AI will really destroy jobs,...
Markets
European Shares Rally on Iran Hopes, but AstraZeneca Drags Down FTSE 100
Stoxx Europe 600 rises 0.45% as hopes grow for a US-Iran deal, while the UK's FTSE 100 slips on a 9% drop in AstraZeneca...
Companies
AstraZeneca and Bristol Myers in Talks Over Potential $400 Billion Pharma Merger
Report says the two drugmakers discussed a merger that would create a $400 billion oncology powerhouse, but the talks co...
Companies
AstraZeneca–BMS Merger Report Sends Shares Tumbling Into Antitrust Spotlight
Investors sold AstraZeneca after a report it held preliminary merger talks with Bristol Myers Squibb, while analysts que...
Companies
AstraZeneca and Bristol Myers Squibb in Talks Over $400bn Pharma Merger
AstraZeneca and Bristol Myers Squibb are in merger talks that could create a nearly $400bn pharmaceutical giant, the Fin...
Markets
FTSE Held Back as AstraZeneca Slumps on $400bn Bristol Myers Talks
AstraZeneca's 6% slide and cheaper oil keep the FTSE behind Europe, as traders turn to US jobs reports ahead of the Fed'...